149 related articles for article (PubMed ID: 1686910)
1. Differential effects of potassium channel blockers on dopamine release from rat striatal slices.
Boireau A; Richard F; Olivier V; Aubeneau M; Miquet JM; Dubédat P; Laduron P; Doble A; Blanchard JC
J Pharm Pharmacol; 1991 Nov; 43(11):798-801. PubMed ID: 1686910
[TBL] [Abstract][Full Text] [Related]
2. The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices.
Schechter LE
J Pharmacol Exp Ther; 1997 Jul; 282(1):262-70. PubMed ID: 9223563
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release.
Cass WA; Zahniser NR
J Neurochem; 1991 Jul; 57(1):147-52. PubMed ID: 1828829
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic effect of 7-OH-DPAT on evoked [3H]-acetylcholine release in rat striatal synaptosomes.
Sanz AG; Hospital S; Badia A; Clos MV
Brain Res; 2000 Aug; 874(2):116-22. PubMed ID: 10960595
[TBL] [Abstract][Full Text] [Related]
5. Effects of ion channel blockers and phorbol ester treatments on [3H]dopamine release and neurotensin facilitation of [3H]dopamine release from rat mesencephalic cells in primary culture.
Brouard A; Pelaprat D; Vial M; Lhiaubet AM; Rostène W
J Neurochem; 1994 Apr; 62(4):1416-25. PubMed ID: 7510781
[TBL] [Abstract][Full Text] [Related]
6. K+ and Ca2+ channel blockers may enhance or depress sympathetic transmitter release via a Ca(2+)-dependent mechanism "upstream" of the release site.
Stjärne L; Stjärne E; Msghina M; Bao JX
Neuroscience; 1991; 44(3):673-92. PubMed ID: 1661385
[TBL] [Abstract][Full Text] [Related]
7. Effects of ions and ionic channel activators or blockers on release of alpha-MSH from perifused rat hypothalamic slices.
Bunel DT; Delbende C; Blasquez C; Jégou S; Vaudry H
Brain Res Mol Brain Res; 1990 Jul; 8(2):167-75. PubMed ID: 1698247
[TBL] [Abstract][Full Text] [Related]
8. Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.
Drukarch B; Kits KS; Leysen JE; Schepens E; Stoof JC
Br J Pharmacol; 1989 Sep; 98(1):113-8. PubMed ID: 2553183
[TBL] [Abstract][Full Text] [Related]
9. Properties of 3,4-diaminopyridine-evoked dopamine and acetylcholine release in rabbit caudate nucleus slices: involvement of facilitatory adenosine A2 receptors or nitric oxide?
Ries V; Hertting G; Jackisch R
Brain Res; 1996 Dec; 743(1-2):303-14. PubMed ID: 9017259
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of four dendrotoxin peptides, 4-aminopyridine and tetraethylammonium on the electrically evoked [3H]noradrenaline release from rat hippocampus.
Hu PS; Benishin C; Fredholm BB
Eur J Pharmacol; 1991 Dec; 209(1-2):87-93. PubMed ID: 1687682
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin modulates differently potassium, veratridine and 4-aminopyridine-evoked release of dopamine in rat striatal slices.
Boireau A; Miquet JM; Olivier V
Fundam Clin Pharmacol; 1993; 7(2):109-14. PubMed ID: 8486330
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of potassium channel blockers on neurohypophysial release of oxytocin and vasopressin. Evidence for frequency-dependent interaction with the endogenous opioid inhibition of oxytocin release.
Racké K; Altes U; Baur AM; Hobbach HP; Jost D; Schäfer J; Wammack R
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):560-6. PubMed ID: 2854213
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats.
Dawson LA; Routledge C
Br J Pharmacol; 1995 Dec; 116(8):3260-4. PubMed ID: 8719805
[TBL] [Abstract][Full Text] [Related]
14. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate.
Büyükuysal RL
Fundam Clin Pharmacol; 1997; 11(6):528-36. PubMed ID: 9444520
[TBL] [Abstract][Full Text] [Related]
15. Relation of [Ca2+]i to dopamine release in striatal synaptosomes: role of Ca2+ channels.
Carvalho CM; Ferreira IL; Duarte CB; Malva JO; Tretter L; Adam-Vizi V; Carvalho AP
Brain Res; 1995 Jan; 669(2):234-44. PubMed ID: 7712179
[TBL] [Abstract][Full Text] [Related]
16. Effect of metaphit on dopaminergic neurotransmission in rat striatal slices: involvement of the dopamine transporter and voltage-dependent sodium channel.
Reith ME; Jacobson AE; Rice KC; Benuck M; Zimanyi I
J Pharmacol Exp Ther; 1991 Dec; 259(3):1188-96. PubMed ID: 1662274
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of aminopyridine-induced release of [3H]dopamine from rat brain synaptosomes.
Scheer HW; Lavoie PA
Gen Pharmacol; 1991; 22(1):169-72. PubMed ID: 1675617
[TBL] [Abstract][Full Text] [Related]
18. 4-Aminopyridine-induced increase in basal and stimulation-evoked [3H]-NA release in slices from rat hippocampus: Ca2+ sensitivity and presynaptic control.
Hu PS; Fredholm BB
Br J Pharmacol; 1991 Mar; 102(3):764-8. PubMed ID: 1364850
[TBL] [Abstract][Full Text] [Related]
19. Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum.
Dobrev D; Ravens U
Eur J Pharmacol; 2003 Feb; 461(2-3):105-11. PubMed ID: 12586205
[TBL] [Abstract][Full Text] [Related]
20. A role for potassium channels in the regulation of cortical muscarinic acetylcholine receptors in an in vitro slice preparation.
Shaw C; van Huizen F; Cynader MS; Wilkinson M
Brain Res Mol Brain Res; 1989 Jan; 5(1):71-83. PubMed ID: 2538705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
